For this week’s VJOncology podcast, we bring you highlights in breast cancer from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Join Oleg Gluz of Evang. Krakenhaus “Bethesda” Klinik, Jana de Boniface of the Karolinska Institutet, Peter Schmid of Queen Mary University of London and Erika Hamilton of the Sarah Cannon Research Institute as they discuss key trials and what this means for clinical practice. They explore pooled analysis from the ADAPT and PlanB trials, results from the SENOMAC trial of axillary lymph node dissection omission, menopausal status data from the lidERA trial, final analysis from KEYNOTE-522 and subgroup analyses from HER2CLIMB-05.